Health
FDA Approves Treatment for Chronic Kidney Disease – StreetInsider.com
SILVER SPRING, Md., April 30, 2021 /PRNewswire/ –Â Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the…
SILVER SPRING, Md., April 30, 2021 /PRNewswire/ – Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression. Â
“Chronic kidney disease is an important public health issue, and there is a significant unmet need for therapies that slow disease progression and improve…
-
Noosa News22 hours agoEnsure voices are heard – Proctor
-
General24 hours agoFederal politics live: Government says RBA rate cut decision about ‘pace, not direction’
-
Noosa News18 hours agoMajor crash on Gateway Motorway snarls morning commute
-
General24 hours agoReserve Bank board still looking for yesterday’s news